Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor

References

• Adnane L, Trail PA, Taylor I, Wilhelm SM. 2006. Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature. Methods Enzymol. 407:597–612.
   PubMed Web of Science ®Google Scholar
• Aiello LP. 2008. Targeting intraocular neovascularization and edema–one drop at a time. N Engl J Med. 359 9: 967–969.
   PubMed Web of Science ®Google Scholar
• Aiello LP, Pierce EA, Foley ED, Takagi H, Chen H, Riddle L, Ferrara N, King GL, Smith LE. 1995. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA. 92 23: 10457–10461.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 22 10: 1276–1312.
   PubMed Web of Science ®Google Scholar
• Antonetti DA, Barber AJ, Bronson SK, Freeman WM, Gardner TW, Jefferson LS, Kester M, Kimball SR, Krady JK, LaNoue KF, Norbury CC, Quinn PG, Sandirasegarane L, Simpson IA. 2006. Diabetic retinopathy: Seeing beyond glucose-induced microvascular disease. Diabetes. 55 9: 2401–2411.
   PubMed Web of Science ®Google Scholar
• Behzadian MA, Wang XL, Al-Shabrawey M, Caldwell RB. 1998. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia. 24 2: 216–225.
   PubMed Web of Science ®Google Scholar
• Bhutto IA, McLeod DS, Hasegawa T, Kim SY, Merges C, Tong P, Lutty GA. 2006. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res. 82 1: 99–110.
   Google Scholar
• Buniatian GH. 1997. Further similarities between astrocytes and perisinusoidal stellate cells of liver (Ito cells): Colocalization of desmin and glial fibrillary acidic protein in astroglial primary cultures. Biol Cell. 89 3: 169–177.
   PubMed Web of Science ®Google Scholar
• Carlomagno F, Anaganti S, Guida T, Salvatore G, Troncone G, Wilhelm SM, Santoro M. 2006. BAY 43-9006 inhibition of oncogenic RET mutants. J Natl Cancer Inst. 98 5: 326–334.
   PubMed Web of Science ®Google Scholar
• Chan-Ling TL, Halasz P, Stone J. 1990. Development of retinal vasculature in the cat: Processes and mechanisms. Curr Eye Res. 9 5: 459–478.
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Rosenfeld PJ. 2009. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration. Curr Opin Ophthalmol. 20 3: 166–174.
   PubMed Web of Science ®Google Scholar
• Congdon N, O'Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P. 2004. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol. 122 4: 477–485.
   PubMed Web of Science ®Google Scholar
• Crocker DJ, Murad TM, Geer JC. 1970. Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol. 13 1: 51–65.
   PubMed Web of Science ®Google Scholar
• Das A, McGuire PG. 2003. Retinal and choroidal angiogenesis: Pathophysiology and strategies for inhibition. Prog Retin Eye Res. 22 6: 721–748.
   PubMed Web of Science ®Google Scholar
• Diago T, Pulido JS, Molina JR, Collett LC, Link TP, Ryan EHJr. 2008. Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration. Mayo Clin Proc. 83 2: 231–234.
   PubMed Web of Science ®Google Scholar
• Dorrell MI, Aguilar E, Jacobson R, Trauger SA, Friedlander J, Siuzdak G, Friedlander M. Maintaining retinal astrocytes normalizes revascularization and prevents vascular pathology associated with oxygen-induced retinopathy. Glia. 2009.
   Web of Science ®Google Scholar
• Ehrlich R, Harris A, Kheradiya NS, Winston DM, Ciulla TA, Wirostko B. 2008. Age-related macular degeneration and the aging eye. Clin Interv Aging. 3 3: 473–482.
   PubMed Web of Science ®Google Scholar
• Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P. 2004. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. Faseb J. 18 2: 338–340.
   PubMed Web of Science ®Google Scholar
• Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM. 2007. Sorafenib in advanced clear-cell renal-cell carcinoma. N Engl J Med. 356 2: 125–134.
   PubMed Web of Science ®Google Scholar
• Esposito G, De Filippis D, Cirillo C, Sarnelli G, Cuomo R, Iuvone T. 2006. The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation. Life Sci. 78 23: 2707–2715.
   PubMed Web of Science ®Google Scholar
• Gardner TW, Lieth E, Khin SA, Barber AJ, Bonsall DJ, Lesher T, Rice K, Brennan WAJr. 1997. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest Ophthalmol Vis Sci. 38 11: 2423–2427.
   PubMed Web of Science ®Google Scholar
• Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. 2003. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol. 161:1163–1177.
   PubMed Web of Science ®Google Scholar
• Ikuno Y, Hibino S, Bando H, Kawasaki Y, Nakamura T, Tano Y. 2002. Retinal glial cells stimulate microvascular pericyte proliferation via fibroblast growth factor and platelet-derived growth factor in vitro. Jpn J Ophthalmol. 46 4: 413–418.
   PubMed Web of Science ®Google Scholar
• Jager RD, Mieler WF, Miller JW. 2008. Age-related macular degeneration. N Engl J Med. 358 24: 2606–2617.
   PubMed Web of Science ®Google Scholar
• Jo N, Mailhos C, Ju M, Cheung E, Bradley J, Nishijima K, Robinson GS, Adamis AP, Shima DT. 2006. Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization. Am J Pathol. 168 6: 2036–2053.
   PubMed Web of Science ®Google Scholar
• Kernt M, Hirneiss C, Neubauer AS, Lackerbauer CA, Eibl KH, Wolf A, Ulbig M, Kampik A.. 2009. Protective effect of blue light-absorbing IOLs on the human retinal pigment epithelium. Ophthalmol [Epub ahead of print].
   Google Scholar
• Kernt M, Neubauer AS, Liegl R, Eibl KH, Alge CS, Lackerbauer CA, Ulbig MW, Kampik A. 2009. Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression. J Cataract Refract Surg. 35 2: 354–362.
   PubMed Web of Science ®Google Scholar
• Kernt M, Neubauer AS, Ulbig MW, Kampik A, Welge-Lussen U. 2008. In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment. J Cataract Refract Surg. 34 3: 480–488.
   PubMed Web of Science ®Google Scholar
• Kernt M, Staehler M, Stief C, Kampik A, Neubauer AS. 2008. Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment. Acta Ophthalmol. 86 4: 456–458.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Vidal I, Pena JD, Hernandez MR. 1997. Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head. Glia. 20 3: 262–273.
   PubMed Web of Science ®Google Scholar
• Lambert W, Agarwal R, Howe W, Clark AF, Wordinger RJ. 2001. Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa. Invest Ophthalmol Vis Sci. 42:2315–2323.
   PubMed Web of Science ®Google Scholar
• Laterra J, Guerin C, Goldstein GW. 1990. Astrocytes induce neural microvascular endothelial cells to form capillary-like structures in vitro. J Cell Physiol. 144 2: 204–215.
   PubMed Web of Science ®Google Scholar
• Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, Wilhelm S, Lynch M, Carter C. 2006. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer Res. 66 24: 11851–11858.
   PubMed Web of Science ®Google Scholar
• Miyake K, Ichihashi S, Shibuya Y, Ota I, Miyake S, Terasaki H. 1999. Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia. J Cataract Refract Surg. 25 7: 891–897.
   PubMed Web of Science ®Google Scholar
• Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 65 1–2: 55–63.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Provis JM, Furby JH, Gatenby PA, Billson FA. 1990. Autoantibodies to retinal astrocytes associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 228 3: 270–274.
   PubMed Web of Science ®Google Scholar
• Penfold PL, Provis JM, Madigan MC, van Driel D, Billson FA. 1990. Angiogenesis in normal human retinal development: The involvement of astrocytes and macrophages. Graefes Arch Clin Exp Ophthalmol. 228 3: 255–263.
   PubMed Web of Science ®Google Scholar
• Peyman GA, Fiscella R, Conway M. 2009. Combination angiostatic therapies: Current status. Retina. 29 6 Suppl: S18–S20.
   Web of Science ®Google Scholar
• Ratain MJ, Eisen T, Stadler WM, Flaherty KT, Kaye SB, Rosner GL, Gore M, Desai AA, Patnaik A, Xiong HQ, Rowinsky E, Abbruzzese JL, Xia C, Simantov R, Schwartz B, O'Dwyer PJ. 2006. Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol. 24 16: 2505–2512.
   PubMed Web of Science ®Google Scholar
• Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY. 2006. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 355 14: 1419–1431.
   PubMed Web of Science ®Google Scholar
• Schlingemann RO. 2004. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 242 1: 91–101.
   PubMed Web of Science ®Google Scholar
• Schlingemann RO, Oosterwijk E, Wesseling P, Rietveld FJ, Ruiter DJ. 1996. Aminopeptidase a is a constituent of activated pericytes in angiogenesis. J Pathol. 179 4: 436–442.
   PubMed Web of Science ®Google Scholar
• Seo MS, Okamoto N, Vinores MA, Vinores SA, Hackett SF, Yamada H, Yamada E, Derevjanik NL, LaRochelle W, Zack DJ, Campochiaro PA. 2000. Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment. Am J Pathol. 157 3: 995–1005.
   PubMed Web of Science ®Google Scholar
• Spaide RF. 2009. Rationale for combination therapy in age-related macular degeneration. Retina. 29 6 Suppl: S5–S7.
   Web of Science ®Google Scholar
• Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chan-Ling T, Keshet E. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15. 19957 Pt 1: 4738–4747.
   PubMed Web of Science ®Google Scholar
• Werner S, Grose R. 2003. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 83 3: 835–870.
   PubMed Web of Science ®Google Scholar
• Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. 2008. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 7 19: 3129–3140.
   PubMedGoogle Scholar
• Wilhelm SM, Carter C, Tang L, Wilkie D, McNabola A, Rong H, Chen C, Zhang X, Vincent P, McHugh M, Cao Y, Shujath J, Gawlak S, Eveleigh D, Rowley B, Liu L, Adnane L, Lynch M, Auclair D, Taylor I, Gedrich R, Voznesensky A, Riedl B, Post LE, Bollag G, Trail PA. 2004. BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis. Cancer Res. 64 19: 7099–7109.
   PubMed Web of Science ®Google Scholar
• Witmer AN, Vrensen GF, Van Noorden CJ, Schlingemann RO. 2003. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res. 22 1: 1–29.
   PubMed Web of Science ®Google Scholar
• Yang J, Yang P, Tezel G, Patil RV, Hernandez MR, Wax MB. 2001. Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest Ophthalmol Vis Sci. 42 2: 365–371.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Stone J. 1997. Role of astrocytes in the control of developing retinal vessels. Invest Ophthalmol Vis Sci. 38 9: 1653–1666.
   PubMed Web of Science ®Google Scholar
• Zhou J, Cai B, Jang YP, Pachydaki S, Schmidt AM, Sparrow JR. 2005. Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells. Exp Eye Res. 80 4: 567–580.
   PubMed Web of Science ®Google Scholar
• Zimmer DB, Cornwall EH, Landar A, Song W. 1995. The S100 protein family: History, function, and expression. Brain Res Bull. 37 4: 417–429.
   PubMed Web of Science ®Google Scholar